TSO

TriSourceObserve

Slow journalism for technology, industry, and capital.

Stories

Capital Flow

Shows how policy, balance sheets, market structure, and investor expectations transmit change across industries.

AllMacro InsightsCorporate StrategyFinTech & Future AssetsSector Deep-dive
TSO / High confidence
Capital FlowSector Deep-dive

Australia’s ARC Training Centre for IOCR Unveils Four Mining Technologies, Moving Into Industry Trials and Deployment

Australia’s ARC Training Centre for Integrated Operations for Complex Resources (IOCR) said in April 2026 that four of its mining technologies have been validated and are ready for industry trials, pilot deployment, and commercial collaboration, while it actively seeks mining companies and technology partners. The three sources agree on the core fact that the technologies are commercially ready and industry engagement is now underway, though they differ slightly in how they describe maturity and cooperation.

May 2, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

CATL and HyperStrong Reach 60 GWh Sodium-Ion Energy Storage Agreement: Multiple Sources Point to a “World’s Largest” Order

CATL and energy storage integrator HyperStrong announced a three-year 60 GWh sodium-ion battery supply/cooperation agreement. Three sources confirm the event is tied to energy storage applications and describe it as the largest sodium-ion battery order or cooperation of its kind to date. However, there are wording differences over whether the agreement is primarily a supply deal or a broader collaboration, and the strength of claims about its impact on commercialization varies; some background details were not mentioned by all sources.

Apr 30, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

Tortugas Neuroscience completes $106 million seed and Series A financing, with Cure Ventures leading

Framingham-based Tortugas Neuroscience announced a $106 million seed and Series A financing led by Cure Ventures, with The Column Group and AN Venture Partners participating. Source alignment confirms the funding amount, lead investor, and participating firms; however, details on the use of proceeds, the scope of the candidate drugs, and the company’s background are not fully consistent across sources, and some information cannot be verified from the provided materials.

Apr 29, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

Omdia Raises 2026 Semiconductor Revenue Growth Forecast to 62.7% as AI Lifts Memory Chip Demand

Omdia has raised its forecast for global semiconductor revenue growth in 2026 to 62.7%. The sources consistently point to AI-driven surging demand for DRAM and NAND, along with ongoing supply shortages. A third-party report citing TrendForce says memory prices will still rise sharply in Q2 2026 and that HBM prioritization is squeezing supply for other end markets. The claim that shortages will continue into 2027 is not directly confirmed by Sources 1 and 2, while Source 3 reflects a different institution’s longer-term supply-demand outlook and cannot be equated with Omdia’s conclusion.

Apr 26, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

Gelmu 60MW Liquid Air Energy Storage Project Draws Attention as Related Projects in the UK and South Korea Emerge Along the Same Industry Trend

Among the three sources, Source 1 explicitly mentions China’s Gelmu 60MW liquid air energy storage project, the advancement of South Korea’s first large-scale liquid air energy storage plant, and a project near Manchester in the UK as well as a larger project queue. Sources 2 and 3 mainly provide broader energy storage context, covering a UK storage overview and U.S. pumped storage, and do not directly supplement the liquid air energy storage storyline. Overall, the only core fact cross-confirmed by all three sources is that liquid air energy storage and the wider energy storage sector continued to attract attention during the same period; project-specific details beyond Source 1 cannot be confirmed by the other two sources.

Apr 23, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

Kailera Therapeutics Completes $625 Million IPO, Advancing Financing for Obesity Drug Pipeline

Kailera Therapeutics completed its IPO in April 2026, pricing shares at $16 each and raising $625 million. Three sources consistently confirm the fundraising size, offering price, and the company’s focus on obesity biopharmaceuticals. However, details such as the number of shares sold, specific use of proceeds, and listing arrangements appear only in individual sources and should be treated separately from the confirmed facts.

Apr 22, 2026
Read analysis